Monday, February 20, 2017 7:09:18 PM
And what about this big drug they've got? https://clinicaltrials.gov/ct2/show/results/NCT02359123
"This study is currently recruiting participants." Haven't even started testing it yet.
And they have spent "Research and development costs charged to expense were $22,133 and $8,397 for the three months ended November 30, 2016 and 2015"
Good luck with this. I am sure they will be MAAAAAAAAAAAJOR competitors to big pharma.
I am sure this has nothing to do with the fact that 4 people own 85% of the shares and are manipulating this stock upward. https://www.otcmarkets.com/financialReportViewer?symbol=CNBX&id=163465
Recent CNBX News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 09:27:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/12/2024 03:13:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/14/2023 02:28:11 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM